Strict appropriate use edicts won't solve our cost problem

11/4/2013 | Bloomberg

Amid the steady drumbeat of warnings about escalating medical costs, clear-cut guidelines for conservative treatment are appealing, writes Megan McArdle, but they are also largely unrealistic and ignore crucial aspects of good clinical care. McArdle's piece follows a New Yorker article by cardiologist Dr. Lisa Rosenbaum that noted guidelines that advance strict treat/don't treat directives are often based around "rarefied environments" in clinical trials that bear little resemblance to real-life treatment scenarios, where challenges such as patient preference and adherence pose real obstacles to helping patients get well.

View Full Article in:

Bloomberg

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ